A Non-canonical Pathway with Potential for Safer Modulation of Transforming Growth Factor-β1 in Steroid-Resistant Airway Diseases

Impaired therapeutic responses to anti-inflammatory glucocorticoids (GC) in chronic respiratory diseases are partly attributable to interleukins and transforming growth factor β1 (TGF-β1). However, previous efforts to prevent induction of GC insensitivity by targeting established canonical and non-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meina, Keenan, Christine R., Lopez-Campos, Guillermo, Mangum, Jonathan E., Chen, Qianyu, Prodanovic, Danica, Xia, Yuxiu C., Langenbach, Shenna Y., Harris, Trudi, Hofferek, Vinzenz, Reid, Gavin E., Stewart, Alastair G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360516/
https://www.ncbi.nlm.nih.gov/pubmed/30711747
http://dx.doi.org/10.1016/j.isci.2019.01.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360516/
https://www.ncbi.nlm.nih.gov/pubmed/30711747
http://dx.doi.org/10.1016/j.isci.2019.01.023

Ejemplares similares